Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) EBT Margin (2016 - 2025)

Historic EBT Margin for Outlook Therapeutics (OTLK) over the last 7 years, with Q3 2025 value amounting to 16175.93%.

  • Outlook Therapeutics' EBT Margin changed N/A to 16175.93% in Q3 2025 from the same period last year, while for Dec 2025 it was 6709.3%, marking a year-over-year change of. This contributed to the annual value of 4526.01% for FY2025, which is 69132300.0% down from last year.
  • As of Q3 2025, Outlook Therapeutics' EBT Margin stood at 16175.93%.
  • In the past 5 years, Outlook Therapeutics' EBT Margin ranged from a high of 16175.93% in Q3 2025 and a low of 1338.75% during Q2 2025